What’s New –American Moderna – a vaccine firm – will be setting up another multi-million plant in Kenya, this being its first on the continent.
The US biotechnology firm announced that it would be pumping a sum of $ 500 million which is equal to sh 56.5 billion into its Kenyan plant that will be tasked with supplying not less than 500 million doses of mRNA vaccines around Africa.
Moderna also disclosed its plans to start filling doses of its Covid-19 vaccine in Africa. This will start as early as next year 2023
“We are pleased to partner with Moderna in the establishment of this mRNA manufacturing facility to help prepare the country and our sister states on the continent through the African Union to respond to future health crises and stave off the next pandemic,” President Uhuru Kenyatta said after announcing the deal.
It is expected that the establishment will address the shortage of vaccines in Africa anytime there is a pandemic like Covid-19.
“Moderna’s investment in Kenya will help advance equitable global vaccine access and is emblematic of the structural developments that will enable Africa to become an engine of sustainable global growth.” Uhuru added.
This good news is coming at the time African nations have piled pressure on their developed counterparts to also ensure the entire world remains safe anytime there is a life threatening outbreak.
